The story of innovative drugs going global has never really cooled down in the past two years. Small biotechs like $TRANSTHERA-B(02617.HK), $LONGBIO-B(01779.HK), and $HJ SCIENCE-B(06132.HK) rely half on their pipelines and half on market sentiment. On the other side of the ocean, $Abbvie(ABBV.US) has a different way of life—a stable cash cow😀.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
